Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Total 0 results
Nothing found
Sponsors and Collaborators
Second Military Medical University
University of Oradea
Daniel Landi
High Technology Medical Center
Lahore General Hospital
Chengdu Shangjin Nanfu Hospital
Saad Amer
Scientific Research Fund, Ministry of Higher Education and Research, Jordan
Euthymics BioScience, Inc.
The Cranberry Institute
Agència de Salut Pública de Catalunya (ASPCAT)
Histocell SL, Spain
Association Française de Pédiatrie Ambulatoire- AFPA
COA Research Foundation, INC
Alphatec Spine, Inc.
Buddy Healthcare Ltd OY
ProbiSearch SL
Huan'an First People's Hospital
Annesofie Faurschou
Hospital General de Cataluña
View Full List
Medical Conditions
Non-specific Chronic Low Back Pain
Sleep Disorder, Shift-Work
5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS
Hospital Accreditation
Children With Complex Chronic Conditions
Invasive Group B Streptococcus Disease Among Non-pregnant Adult
Degloving Injury
Heel Spur
Cutaneous Metastatic Melanoma
Mouse Allergy
Current Depressive Episode
Blasts 5 Percent or More of Peripheral Blood White Cells
Age 50 - 74 for Females or 60-74 for Males
RVOT Anomaly
CVD Risk
Biliary and Pancreatic Stones
Long Term Neurobehavioral Effects
Hematopoietic Stem Cell Transplant
HPV-unrelated Head and Neck Squamous Cell Carcinoma
Dissection, Aortic
View Full List
Drug Interventions
IV Fludarabine
AMG 531
CMX-2043
Nitrous Oxide
Leflunomide 20 mg Tablets
Camrelizumab
Fluocinolone Acetonide
Fresolimumab
IBI-323 combined with bevacizumab plus Platinum
TPF induction chemotherapy
INCMGA00012
Intranasal oxytocin
VV119(SAD)
OSI-774 (Tarceva)
Gemtuzumab Ozogamicin
CA9hu-1
IFN-alpha
ACT-451840:
Methotrexate
MMH-MAP
View Full List
CROs by country
Contract Research Organizations in Belgium
Contract Research Organizations in Brazil
Contract Research Organizations in Canada
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Guatemala
Contract Research Organizations in Hungary
Contract Research Organizations in Indonesia
Contract Research Organizations in Luxembourg
Contract Research Organizations in Mauritania
Contract Research Organizations in Saint Lucia
Contract Research Organizations in Suriname
Contract Research Organizations in United States
Contract Research Organizations in Venezuela
CRO list by country
CROs in Bahrain
SGS
All CROs in Bahrain
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe